机读格式显示(MARC)
- 000 02327cam a2200397 i 4500
- 008 220826s2022 sz a o 000 0 eng d
- 020 __ |a 9783030659202 |q (electronic bk.)
- 020 __ |a 3030659208 |q (electronic bk.)
- 035 __ |a (OCoLC)1342443405 |z (OCoLC)1341985733 |z (OCoLC)1354541555
- 040 __ |a GW5XE |b eng |e rda |c GW5XE |d EBLCP |d YDX |d OCLCF |d N$T
- 082 04 |a 615.5/32 |2 23/eng/20220826
- 245 00 |a Materia medica of new and old homeopathic medicines / |c David S. Riley (editor)
- 260 __ |a Cham : |b Springer, |c 2022
- 300 __ |a 1 volume : |b illustrations (colour) ; |c 24 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 500 __ |a Previous edition: 2017
- 504 __ |a Includes bibliographical references
- 520 __ |a Materia Medica of New and Old Homeopathic Medicines David S. Rileys interest in the research and subsequently the history and methodology of homeopathic drug provings began with his medical school training in 1979 and a residency in Internal Medicine. He was exposed to homeopathy in 1988 followed by study at the Hahnemann College of Homeopathy in Albany, California. He has investigated the interplay between contemporary research methods and the research methods associated with homeopathic drug provings. Dr Riley has developed research tools for data collection, symptom selection criteria and blinding; primarily to address the risk of bias. The homeopathic drug provings published here are the result of this work. For the 3rd edition twelve homeopathic drug provings, conducted by a number of internationally renowned proving directors, have been added. These homeopathic drug provings all follow good clinical practice (GCP) research guidelines and incorporate the guidelines suggested by Dr Samuel Hahnemann more than 200 years ago
- 650 _0 |a Homeopathy |x Materia medica and therapeutics.
- 650 _0 |a Homeopathy |x Research.
- 650 12 |a Materia Medica.
- 700 1_ |a Riley, David S., |c M.D., |e editor
- 710 2_ |a Ohio Library and Information Network.